Exhibit 99.1
LORUS THERAPEUTICS INC.
Report of Voting Results
This report is filed pursuant to Section 11.3 of National Instrument 51-102 and relates to the results of voting at the special meeting of securityholders of Lorus Therapeutics Inc. held on June 25, 2007.
Description of Matter | Outcome of Vote | |
Resolution to approve a proposed plan of arrangement involving Lorus Therapeutics Inc., NuChem Pharmaceuticals Inc., GeneSense Technologies Inc., 6650309 Canada Inc., Pinnacle International Lands, Inc. and 6707157 Canada Inc. | Resolution passed by the required majorities. Details of the voting as follows: 1. Vote of all Securityholders: Total votes cast in favour: 106,423,847 (99.39%) Total votes cast against: 651,818 (0.61%) 2. Vote of Minority Shareholders Only: Total votes cast in favour: 48,210,493 (98.7%) Total votes cast against: 637,218 (1.3%) |
DATED this 26th day of June, 2007.
LORUS THERAPEUTICS INC.
By: (signed) Aiping Young, President and Chief Executive Officer